![Michelle Doig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Doig
Founder at
OMEGA ALPHA SPAC
Profile
Michelle Doig is the founder of Omega Alpha SPAC, founded in 2020, serving as President & Director.
Current jobs include Independent Director at Bridgebio Oncology Therapeutics, Inc. since 2024; Director at Artios Pharma Ltd. since 2021; Director at Nuvation Bio Operating Co., Inc.; and Partner & Head-Corporate Development at Omega Fund Management LLC since 2016.
Former jobs include Director-Corporate Finance at Third Rock Ventures LLC from 2013 to 2016; Director at Nuvation Bio, Inc. from 2019 to 2021; Director at Bridgebio Oncology Therapeutics, Inc. from 2025 to 2026; Associate at Lehman Brothers, Inc. from 2001 to 2002; Analyst at Morgan Stanley from 1996 to 1998; Principal at Abingworth LLP from 2004 to 2013; Associate at J.P.
Morgan & Co., Inc. (Delaware) from 1998 to 2001; and Manager at Student Works Management Program from 1993 to 1995.
Education includes undergraduate studies at Richard Ivey School of Business.
Michelle Doig active positions
| Companies | Position | Start |
|---|---|---|
| OMEGA ALPHA SPAC | Founder | 31/10/2020 |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Private Equity Investor | 31/12/2015 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Director/Board Member | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Director/Board Member | 30/06/2021 |
Former positions of Michelle Doig
| Companies | Position | End |
|---|---|---|
| NUVATION BIO INC. | Director/Board Member | 30/07/2021 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Private Equity Investor | 30/12/2016 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 31/10/2013 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 31/12/2001 |
Training of Michelle Doig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
J.P. Morgan & Co., Inc. (Delaware)
 J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Finance |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Omega Alpha SPAC
 Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
- Stock Market
- Insiders
- Michelle Doig
